TP53 and small cell lung carcinoma: Similarly, another study in China revealed that TP53, RB1, and KMT2D are the most common mutations in Chinese patients with SCLC, and other novel genes (LRRK2, BRCA1, PTCH1, ARID2, and APC) are observed in 90% of these patients [125].